Kestra Medical Technologies Ltd.
KMTS | NASDAQ
$24.77
+$0.34 (+1.39%)
At close: Sep 21, 2026, 4:00 PM ET
$24.77
$0 (0.00%)
Pre-market:
Sep 22, 2026, 4:30 AM ET
Market Data
Market Cap $1.45B
Enterprise Value $1.26B
Beta 0.62
Average Volume 335.73K
Shares Outstanding (Diluted) 58.57M
Shares Change YoY 14.15%
Institutional Ownership N/A
Exchange NASDAQ
ISIN BMG524411052
Price Performance
Price Change 1M -8.2%
Price Change 3M 19.7%
Price Change 6M 20.4%
Price Change YTD 1.6%
Price Change 1Y -3.0%
Price Change 3Y 18.0%
Price Change 5Y 18.0%
1M CAGR (ann.) -6.2%
1Y CAGR (ann.) -1.7%
5Y CAGR (ann.) N/A
All-Time CAGR 8.5%
Valuation
PE Ratio -9.28
Forward PE N/A
PEG Ratio -0.59
Forward PEG 0.67
PS Ratio 13.60
Forward PS 10.30
PB Ratio 6.53
P/FCF Ratio -11.82
P/Adj. FCF Ratio -9.61
P/OCF Ratio -16.51
EV/Sales 11.77
EV/EBIT -8.97
EV/EBITDA -8.58
EV/FCF -10.23
Earnings Yield -10.8%
FCF Yield -8.5%
Adj. FCF Yield -10.4%
Financial Health
Net Cash $194.98M
Total Debt $3.95M
Cash & Short-Term Investments $198.91M
Total Assets $347.36M
Current Ratio 4.69
Quick Ratio 4.69
Debt / Equity Ratio 0.34
Debt / EBITDA -0.03
Debt / FCF -0.03
OCF / Debt -22.20
Interest Coverage -18.98
Altman Z-Score 3.75
Piotroski F-Score 5
Margins & Profitability
Gross Profit Margin 53.9%
Operating Profit Margin -134.5%
EBITDA Margin -134.8%
Net Profit Margin -140.4%
FCF Margin -115.0%
Adj. FCF Margin -141.5%
SBC / Revenue 26.5%
SBC Impact (per share) -23.0%
Returns
Return on Assets -43.1%
Return on Equity -64.2%
Return on Invested Capital -48.0%
Return on Capital Employed -48.0%
Return on Tangible Assets -43.1%
Historical Growth (CAGR)
Revenue CAGR 3Y 55.5%
Revenue CAGR 5Y N/A
Revenue CAGR 10Y N/A
EPS CAGR 3Y -25.2%
EPS CAGR 5Y N/A
EPS CAGR 10Y N/A
FCF CAGR 3Y -29.3%
FCF CAGR 5Y -22.6%
FCF CAGR 10Y N/A
Analyst Forecasts
Analyst Rating Buy
Analyst Count 4
EPS Growth Next 3Y 11.6%
Revenue Growth Next 3Y 34.4%
Earnings Date Dec 9, 2026
EPS Estimate (next Q) -$0.61
EPS Growth Est (next Q) -1.6%
Revenue Est (next Q) $32.03M
Revenue Growth Est (next Q) 41.9%
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $30.67
Price Target Upside 23.8%
Cash Flow
Operating Cash Flow $-87.72M
Free Cash Flow $-122.79M
Adj. Free Cash Flow $-151.06M
FCF Per Share -$2.10
OCF Per Share -$1.50
OCF/S Ratio -82.2%
Income Statement
Revenue $106.73M
Gross Profit $57.51M
Operating Income $-143.52M
EBITDA $-146.52M
Net Income $-149.87M
EPS (Diluted) -$2.67
Revenue / Employee $240.92K
Profit / Employee $-338.31K
Employees 443
Add to Watchlist
Select watchlists to add or remove KMTS